BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20504773)

  • 1. A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity.
    Gable K; Gupta SD; Han G; Niranjanakumari S; Harmon JM; Dunn TM
    J Biol Chem; 2010 Jul; 285(30):22846-52. PubMed ID: 20504773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.
    Bode H; Bourquin F; Suriyanarayanan S; Wei Y; Alecu I; Othman A; Von Eckardstein A; Hornemann T
    Hum Mol Genet; 2016 Mar; 25(5):853-65. PubMed ID: 26681808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The external aldimine form of serine palmitoyltransferase: structural, kinetic, and spectroscopic analysis of the wild-type enzyme and HSAN1 mutant mimics.
    Raman MCC; Johnson KA; Yard BA; Lowther J; Carter LG; Naismith JH; Campopiano DJ
    J Biol Chem; 2009 Jun; 284(25):17328-17339. PubMed ID: 19376777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy.
    McCampbell A; Truong D; Broom DC; Allchorne A; Gable K; Cutler RG; Mattson MP; Woolf CJ; Frosch MP; Harmon JM; Dunn TM; Brown RH
    Hum Mol Genet; 2005 Nov; 14(22):3507-21. PubMed ID: 16210380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pyridoxal 5'-phosphate (PLP)-dependent enzyme serine palmitoyltransferase (SPT): effects of the small subunits and insights from bacterial mimics of human hLCB2a HSAN1 mutations.
    Beattie AE; Gupta SD; Frankova L; Kazlauskaite A; Harmon JM; Dunn TM; Campopiano DJ
    Biomed Res Int; 2013; 2013():194371. PubMed ID: 24175284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1.
    Eichler FS; Hornemann T; McCampbell A; Kuljis D; Penno A; Vardeh D; Tamrazian E; Garofalo K; Lee HJ; Kini L; Selig M; Frosch M; Gable K; von Eckardstein A; Woolf CJ; Guan G; Harmon JM; Dunn TM; Brown RH
    J Neurosci; 2009 Nov; 29(46):14646-51. PubMed ID: 19923297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis.
    Bejaoui K; Uchida Y; Yasuda S; Ho M; Nishijima M; Brown RH; Holleran WM; Hanada K
    J Clin Invest; 2002 Nov; 110(9):1301-8. PubMed ID: 12417569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.
    Garofalo K; Penno A; Schmidt BP; Lee HJ; Frosch MP; von Eckardstein A; Brown RH; Hornemann T; Eichler FS
    J Clin Invest; 2011 Dec; 121(12):4735-45. PubMed ID: 22045570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel HSAN1 mutation in serine palmitoyltransferase resides at a putative phosphorylation site that is involved in regulating substrate specificity.
    Ernst D; Murphy SM; Sathiyanadan K; Wei Y; Othman A; Laurá M; Liu YT; Penno A; Blake J; Donaghy M; Houlden H; Reilly MM; Hornemann T
    Neuromolecular Med; 2015 Mar; 17(1):47-57. PubMed ID: 25567748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Variant (Asn177Asp) in SPTLC2 Causing Hereditary Sensory Autonomic Neuropathy Type 1C.
    Suriyanarayanan S; Othman A; Dräger B; Schirmacher A; Young P; Mulahasanovic L; Hörtnagel K; Biskup S; von Eckardstein A; Hornemann T; Lone MA
    Neuromolecular Med; 2019 Jun; 21(2):182-191. PubMed ID: 30955194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of the serine palmitoyltransferase complex responsible for sphingoid base synthesis by using affinity peptide chromatography techniques.
    Hanada K; Hara T; Nishijima M
    J Biol Chem; 2000 Mar; 275(12):8409-15. PubMed ID: 10722674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.
    Penno A; Reilly MM; Houlden H; Laurá M; Rentsch K; Niederkofler V; Stoeckli ET; Nicholson G; Eichler F; Brown RH; von Eckardstein A; Hornemann T
    J Biol Chem; 2010 Apr; 285(15):11178-87. PubMed ID: 20097765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated.
    Hornemann T; Penno A; Richard S; Nicholson G; van Dijk FS; Rotthier A; Timmerman V; von Eckardstein A
    Neurogenetics; 2009 Apr; 10(2):135-43. PubMed ID: 19132419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate Availability of Mutant SPT Alters Neuronal Branching and Growth Cone Dynamics in Dorsal Root Ganglia.
    Jun BK; Chandra A; Kuljis D; Schmidt BP; Eichler FS
    J Neurosci; 2015 Oct; 35(40):13713-9. PubMed ID: 26446223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the yeast LCB1 and LCB2 genes, including those corresponding to the hereditary sensory neuropathy type I mutations, dominantly inactivate serine palmitoyltransferase.
    Gable K; Han G; Monaghan E; Bacikova D; Natarajan M; Williams R; Dunn TM
    J Biol Chem; 2002 Mar; 277(12):10194-200. PubMed ID: 11781309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the ORMDLS, modulators of serine palmitoyltransferase, is regulated by sphingolipids in mammalian cells.
    Gupta SD; Gable K; Alexaki A; Chandris P; Proia RL; Dunn TM; Harmon JM
    J Biol Chem; 2015 Jan; 290(1):90-8. PubMed ID: 25395622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.
    Gantner ML; Eade K; Wallace M; Handzlik MK; Fallon R; Trombley J; Bonelli R; Giles S; Harkins-Perry S; Heeren TFC; Sauer L; Ideguchi Y; Baldini M; Scheppke L; Dorrell MI; Kitano M; Hart BJ; Cai C; Nagasaki T; Badur MG; Okada M; Woods SM; Egan C; Gillies M; Guymer R; Eichler F; Bahlo M; Fruttiger M; Allikmets R; Bernstein PS; Metallo CM; Friedlander M
    N Engl J Med; 2019 Oct; 381(15):1422-1433. PubMed ID: 31509666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I.
    Rotthier A; Penno A; Rautenstrauss B; Auer-Grumbach M; Stettner GM; Asselbergh B; Van Hoof K; Sticht H; Lévy N; Timmerman V; Hornemann T; Janssens K
    Hum Mutat; 2011 Jun; 32(6):E2211-25. PubMed ID: 21618344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I.
    Rotthier A; Auer-Grumbach M; Janssens K; Baets J; Penno A; Almeida-Souza L; Van Hoof K; Jacobs A; De Vriendt E; Schlotter-Weigel B; Löscher W; Vondráček P; Seeman P; De Jonghe P; Van Dijck P; Jordanova A; Hornemann T; Timmerman V
    Am J Hum Genet; 2010 Oct; 87(4):513-22. PubMed ID: 20920666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of dietary alanine toxicity and trafficking dysfunction in a Drosophila model of hereditary sensory and autonomic neuropathy type 1.
    Oswald MC; West RJ; Lloyd-Evans E; Sweeney ST
    Hum Mol Genet; 2015 Dec; 24(24):6899-909. PubMed ID: 26395456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.